Dual time point [18F]Flurodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) with water gastric distension in differentiation between malignant and benign gastric lesions

被引:1
作者
Farghaly, Hussein [1 ,2 ]
Alshareef, Mohamed [2 ]
Alqarni, Abdullah [2 ]
Sayed, Mohamed [1 ]
Nasr, Hatem [2 ,3 ]
机构
[1] Assiut Univ, Fac Med, Dept Oncol & Nucl Med, Assiut, Egypt
[2] Prince Sultan Mil Med City, Dept Radiol, Riyadh, Saudi Arabia
[3] Cairo Univ, Fac Med, Dept Oncol & Nucl Med, Cairo, Egypt
关键词
18F]Flurodeoxyglucose positron emission tomography/Computed tomography (F-18 FDG PET/CT); Dual time point imaging; Gastric malignancy; Water gastric distension; F-18-FDG PET; ORAL CONTRAST; FOLLOW-UP; CANCER; DIAGNOSIS; STOMACH; PITFALLS; EXPRESSION; CARCINOMA; TUMOR;
D O I
10.1016/j.ejro.2020.100268
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: To assess diagnostic accuracy and added value of dual time point F-18-FDG PET/CT after gastric distention using oral water in differentiating malignant from benign gastric lesions. Methods: Patients (n = 30, 19 males, mean age 58.6 +/- 16.4 years). All patients are known or suspected oncology patients. All patients underwent whole body F-18-FDG PET/CT scan and 2 h delayed PET/CT abdominal images following oral water gastric distension. The best cut off values for early SUVmax (SUVmax1), delayed SUVmax (SUVmax2) and SUVmax2-SUVmax1 (Delta SUVmax) to differentiate benign from malignant lesions were set based on ROC analysis. Data analyzed included in addition; age, sex and F-18-FDG uptake pattern in delayed images. Suspicious gastric lesions were correlated with biopsy in 18 patients (60 %) and with clinical and follow-up imaging (F-18-FDG PET/CT, CT or MRI) in 12 patients (40 %). Unpaired t-test was used to compare the mean deference in continuous variables between patients with gastric malignancy and those with benign gastric lesions. Fisher's exact test was used to analyze categorical variables. Logistic regression analysis was performed to identify the most powerful factors to predict malignant lesions. Results: Fifteen patients (50 %) had confirmed malignant gastric lesions. Patients with confirmed gastric malignancy were older (65 +/- 13 vs 52 +/- 17; p = 0.023) and had significantly higher mean Delta SUVmax (1.29 +/- 1.76 vs 0.89 +/- 1.59; p = 0.003). The mean SUVmax1 (6.99 +/- 6.66 vs 5.31 +/- 2.53; p = 0.367) and SUVmax2 (8.29 +/- 7.41 vs 4.44 +/- 3.34; p = 0.077) although both higher in patients with malignant lesions, they did not reach statistical significance. Sensitivity, specificity, PPV, NPV, and accuracy to detect malignant gastric lesions were highest for lesions with localized uptake pattern in delayed images post water oral contrast as well as for lesions with Delta SUVmax>0. Regression analysis revealed both variables as independent predictors for malignant lesions with odd ratios of 22.9 and 9.5 respectively and final model Chi-Square of 19.9 (p < 0.0001). The model correctly identified 12/15 (80 %) malignant lesions and 13/15 (86.7 %) benign lesions with 2 false positives confirmed as chronic active gastritis with helicobacter pylori and 3 false negatives including 1 signet ring gastric cancer and 1 low grade gastrointestinal stromal tumor (GIST), both with poor 18 F-FDG uptake. Conclusion: Localized uptake pattern in delayed PET/CT images following gastric distention with oral water contrast as well as Delta SUVmax>0 are powerful independent variables to identify malignant gastric lesions with fairly high sensitivity and reasonable accuracy. Malignancies with inherently low F-18-FDG avidity are the main cause of false negatives while active gastritis is the main cause of false positives.
引用
收藏
页数:8
相关论文
共 56 条
[1]   COMPUTED-TOMOGRAPHY OF THE STOMACH WITH WATER AS AN ORAL CONTRAST AGENT - TECHNIQUE AND PRELIMINARY-RESULTS [J].
BAERT, AL ;
ROEX, L ;
MARCHAL, G ;
HERMANS, P ;
DEWILDE, D ;
WILMS, G .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1989, 13 (04) :633-636
[2]   Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer? [J].
Basu, Sandip ;
Alavi, Abass .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (10) :1527-1529
[3]   FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases [J].
Charest, Mathieu ;
Hickeson, Marc ;
Lisbona, Robert ;
Novales-Diaz, Javier-A. ;
Derbekyan, Vilma ;
Turcotte, Robert E. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (12) :1944-1951
[4]   Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography [J].
Chen, J ;
Cheong, JH ;
Yun, MJ ;
Kim, J ;
Lim, JS ;
Hyung, WJ ;
Noh, SH .
CANCER, 2005, 103 (11) :2383-2390
[5]  
Chen YY, 1998, MODERN PATHOL, V11, P950
[6]   When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? [J].
Cheng, Gang ;
Torigian, Drew A. ;
Zhuang, Hongming ;
Alavi, Abass .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (05) :779-787
[7]  
Cohade C, 2003, J NUCL MED, V44, P412
[8]   Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine [J].
Cook, GJR ;
Maisey, MN ;
Fogelman, I .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (10) :1363-1378
[9]   Evaluation of Dual Time Point Imaging 18F-FDG PET/CT in Differentiating Malignancy From Benign Gastric Disease [J].
Cui, Jing ;
Zhao, Panxiong ;
Ren, Zhentai ;
Liu, Baoping .
MEDICINE, 2015, 94 (33) :e1356
[10]  
Demura Y, 2003, J NUCL MED, V44, P540